Roche Holding Ltd
Total Valuation
EURAs of June 30, 2026, Roche Holding Ltd carries a market capitalization of 249.46B, placing it among publicly traded companies globally. Its enterprise value stands at 277.73B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 249.46B |
| Enterprise Value | 277.73B |
Share Statistics
As of June 30, 2026, Roche Holding Ltd has 690.07M shares outstanding.
| Shares Outstanding | 690.07M |
Valuation Ratios
These figures are as of June 30, 2026.
| PB Ratio | 7.04 |
| P/TBV Ratio | 41.08 |
Financial Position
As of June 30, 2026, Roche Holding Ltd maintains a current ratio of 1.23, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.23 |
| Quick Ratio | 0.34 |
| Debt / Equity | 86.62 |
Stock Price Statistics
EURThese figures are as of the close on October 22, 2026.
| 50-Day Moving Average | 385.12 |
Balance Sheet
EURAs of June 30, 2026, Roche Holding Ltd holds 10.55B in cash and equivalents against 34.46B in total debt, resulting in a net debt position of 28.56B. Total book value stands at 35.42B, with working capital of 7.14B providing operational flexibility.
| Cash & Cash Equivalents | 10.55B |
| Total Debt | 34.46B |
| Net Debt | 28.56B |
| Equity (Book Value) | 35.42B |
| Book Value Per Share | 51.33 |
| Working Capital | 7.14B |
Stock Splits
Roche Holding Ltd's most recent stock split took place on May 4, 2001 with a 1:100 split ratio.
| Last Split Date | 5/4/2001 |
| Split Ratio | 1:100 |